Search research articles
Contact Us
Filters
Showing results (41-50 of 46) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 46 results.
European Journal of Cancer (Oxford, England : 1990)
|
February 12, 2025
Disease-free survival as surrogate for overall survival in esophageal cancer: An individual patient data meta-analysis of neoadjuvant chemotherapy and chemoradiotherapy
Nicolas Cabrit, Maurice Cheugoua-Zanetsie, Jayne Tierney, et al.
JAMA Network Open
|
August 2, 2024
Preoperative Chemoradiotherapy vs Chemotherapy for Adenocarcinoma of the Esophagogastric Junction: A Network Meta-Analysis
Ulrich Ronellenfitsch, Juliane Friedrichs, Emilie Barbier, et al.
The Lancet. Oncology
|
August 1, 2017
Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis
Benjamin Lacas, Jean Bourhis, Jens Overgaard, et al.
Lancet (London, England)
|
February 14, 2021
Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme
Ruth E Langley, Duncan C Gilbert, Trinh Duong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 19, 2023
Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma
Matthieu Faron, Maurice Cheugoua-Zanetsie, Jayne Tierney, et al.
The New England Journal of Medicine
|
March 25, 2026
Transdermal Estradiol Patches in Locally Advanced Prostate Cancer
Ruth E Langley, Duncan C Gilbert, Stephen Mangar, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 46) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 46 results.
European Journal of Cancer (Oxford, England : 1990)
|
February 12, 2025
Disease-free survival as surrogate for overall survival in esophageal cancer: An individual patient data meta-analysis of neoadjuvant chemotherapy and chemoradiotherapy
Nicolas Cabrit, Maurice Cheugoua-Zanetsie, Jayne Tierney, et al.
JAMA Network Open
|
August 2, 2024
Preoperative Chemoradiotherapy vs Chemotherapy for Adenocarcinoma of the Esophagogastric Junction: A Network Meta-Analysis
Ulrich Ronellenfitsch, Juliane Friedrichs, Emilie Barbier, et al.
The Lancet. Oncology
|
August 1, 2017
Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis
Benjamin Lacas, Jean Bourhis, Jens Overgaard, et al.
Lancet (London, England)
|
February 14, 2021
Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme
Ruth E Langley, Duncan C Gilbert, Trinh Duong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 19, 2023
Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma
Matthieu Faron, Maurice Cheugoua-Zanetsie, Jayne Tierney, et al.
The New England Journal of Medicine
|
March 25, 2026
Transdermal Estradiol Patches in Locally Advanced Prostate Cancer
Ruth E Langley, Duncan C Gilbert, Stephen Mangar, et al.
Page
of 5